Metropolitan Life Insurance Company (MetLife)’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,314
| Closed | -$351K | – | 2957 |
|
|
2021
Q1 | $351K | Hold |
9,314
| – | – | 0.01% | 1645 |
|
|
2020
Q4 | $158K | Buy |
+9,314
| New | +$158K | ﹤0.01% | 2096 |
|
|
2019
Q3 | – | Sell |
-13,283
| Closed | -$80.1K | – | 2653 |
|
|
2019
Q2 | $80.1K | Hold |
13,283
| – | – | ﹤0.01% | 2418 |
|
|
2019
Q1 | $178K | Hold |
13,283
| – | – | ﹤0.01% | 1972 |
|
|
2018
Q4 | $124K | Hold |
13,283
| – | – | ﹤0.01% | 2133 |
|
|
2018
Q3 | $185K | Hold |
13,283
| – | – | ﹤0.01% | 2053 |
|
|
2018
Q2 | $210K | Buy |
13,283
+3,604
| +37% | +$57K | ﹤0.01% | 1907 |
|
|
2018
Q1 | $166K | Buy |
9,679
+635
| +7% | +$10.9K | ﹤0.01% | 2007 |
|
|
2017
Q4 | $198K | Sell |
9,044
-10,289
| -53% | -$225K | ﹤0.01% | 1917 |
|
|
2017
Q3 | $791K | Hold |
19,333
| – | – | 0.01% | 1393 |
|
|
2017
Q2 | $582K | Hold |
19,333
| – | – | ﹤0.01% | 1577 |
|
|
2017
Q1 | $699K | Hold |
19,333
| – | – | ﹤0.01% | 1431 |
|
|
2016
Q4 | $969K | Sell |
19,333
-542
| -3% | -$27.2K | 0.01% | 1312 |
|
|
2016
Q3 | $1.04M | Hold |
19,875
| – | – | 0.01% | 1255 |
|
|
2016
Q2 | $822K | Buy |
19,875
+1,908
| +11% | +$78.9K | 0.01% | 1370 |
|
|
2016
Q1 | $730K | Buy |
17,967
+2,430
| +16% | +$98.7K | 0.01% | 1340 |
|
|
2015
Q4 | $645K | Buy |
15,537
+420
| +3% | +$17.4K | 0.01% | 1460 |
|
|
2015
Q3 | $233K | Hold |
15,117
| – | – | ﹤0.01% | 2177 |
|
|
2015
Q2 | $376K | Buy |
15,117
+1,012
| +7% | +$25.2K | ﹤0.01% | 1949 |
|
|
2015
Q1 | $322K | Hold |
14,105
| – | – | ﹤0.01% | 1798 |
|
|
2014
Q4 | $381K | Hold |
14,105
| – | – | ﹤0.01% | 1954 |
|
|
2014
Q3 | $165K | Hold |
14,105
| – | – | ﹤0.01% | 2512 |
|
|
2014
Q2 | $219K | Buy |
+14,105
| New | +$219K | ﹤0.01% | 2455 |
|